Green Tea Epigallocatechin Gallate (EGCG) and Antioxidants

epigallocatechin gallate and Antioxidants — scientific infographic poster

Epigallocatechin-3-gallate (epigallocatechin gallate, EGCG) is the most extensively studied single polyphenol in nutritional science. It comprises roughly 50-80% of the catechin fraction in green tea, accounts for the majority of the bitter astringent mouthfeel, and is the molecule responsible for nearly every laboratory and clinical antioxidant endpoint that distinguishes green tea from other beverages. Yet "antioxidant" is the easy half of the story. Epigallocatechin gallate's real biology is more interesting: it is a relatively weak direct radical scavenger compared to vitamin C or glutathione, but a potent inducer of the body's endogenous antioxidant enzyme machinery through the Nrf2/Keap1 pathway. And at high purified-extract doses, it inverts to a pro-oxidant capable of hepatocyte injury. This page walks through the chemistry, the mechanism, the human evidence, and the dose-toxicity inversion that explains why the brewed beverage is exceptionally safe while the concentrated capsule is not.


Table of Contents

  1. Epigallocatechin Gallate Chemistry — The Galloyl Ester and Eight Hydroxyls
  2. Direct Radical Scavenging
  3. The Nrf2 / Keap1 Antioxidant Response Pathway
  4. Iron Chelation and the Mealtime Question
  5. Epigallocatechin Gallate Bioavailability — The Real-World Plasma Curve
  6. Dose-Response and the Effective Cup Count
  7. The Dose-Toxicity Inversion (Pro-Oxidant Behavior)
  8. Hepatotoxicity and the European Food Safety Authority 800 mg Finding
  9. Concentrated Supplement Versus Brewed Beverage
  10. Drug Interactions and Cautions
  11. Key Research Papers
  12. Connections
  13. Featured Videos

Epigallocatechin Gallate Chemistry — The Galloyl Ester and Eight Hydroxyls

Catechins are a subclass of flavonoids called flavan-3-ols. Their two-ring core (A-ring fused to a pyranose, joined to a B-ring) carries hydroxyl groups whose count and arrangement determine the molecule's antioxidant chemistry. Four major catechins are present in green tea: epicatechin (EC), epigallocatechin (EGC), epicatechin gallate (ECG), and epigallocatechin-3-gallate (epigallocatechin gallate). Of these, epigallocatechin gallate is by far the most abundant (50-80% of catechin mass in typical Japanese sencha) and the most pharmacologically active.

The "epigallo" prefix means the B-ring carries three adjacent hydroxyls (3', 4', 5' positions) in a vicinal triol arrangement. The "gallate" suffix means a galloyl ester — another three-hydroxyl gallic acid moiety — is attached to the 3-position of the C-ring. The net result is a single molecule carrying eight phenolic hydroxyl groups, all of which can donate a hydrogen atom or an electron to neutralize a radical species. This is unusually dense reducing power for a small molecule of just under 460 Daltons.

The vicinal triol arrangement on the B-ring also gives epigallocatechin gallate its characteristic ability to chelate divalent metal cations — iron, copper, zinc, calcium — through coordination at the two adjacent hydroxyls. The galloyl ester at the 3-position contributes additional chelation sites. This polyphenol-metal binding is the chemistry behind both the iron-absorption interaction (a real and clinically meaningful effect on non-heme iron uptake) and a substantial portion of the indirect antioxidant effect: chelating iron prevents it from catalyzing Fenton-reaction hydroxyl radical generation in the first place.

Back to Table of Contents

Direct Radical Scavenging

The simplest mechanism by which epigallocatechin gallate behaves as an antioxidant is direct radical scavenging: a hydroxyl, peroxyl, superoxide, or other reactive species encounters an epigallocatechin gallate molecule, abstracts a hydrogen atom from one of the eight phenolic hydroxyls, and is thereby quenched. Epigallocatechin gallate itself becomes a relatively stable phenoxyl radical, stabilized by resonance across the aromatic ring, and can either be regenerated by ascorbate or further oxidized to a quinone.

In standard test-tube assays (DPPH, ABTS, ORAC), epigallocatechin gallate scores extremely high — often higher than ascorbic acid on a molar basis and orders of magnitude higher than alpha-tocopherol. This is why early enthusiasm cast green tea as the "highest antioxidant beverage." The problem with extrapolating from test-tube assays to humans is that plasma epigallocatechin gallate concentrations after drinking tea are quite low — peak concentrations rarely exceed 1 micromolar, compared to ascorbate at 50-80 micromolar and urate at 200-300 micromolar. On a population basis, ascorbate, urate, and reduced glutathione vastly outweigh epigallocatechin gallate as direct radical scavengers in human plasma.

The implication is that direct radical scavenging by epigallocatechin gallate, while real, is probably not the dominant mechanism by which green tea consumption translates into measurable antioxidant benefit in humans. The more important mechanism is indirect: epigallocatechin gallate induces the body's own endogenous antioxidant enzyme machinery to produce more glutathione, more superoxide dismutase, more catalase, and more glutathione peroxidase. That mechanism — the Nrf2/Keap1 pathway — is the topic of the next section.

Back to Table of Contents

The Nrf2 / Keap1 Antioxidant Response Pathway

Nrf2 (nuclear factor erythroid 2-related factor 2) is the master transcription factor controlling the cell's antioxidant response. Under basal conditions, Nrf2 is held in the cytoplasm by Keap1 (Kelch-like ECH-associated protein 1), which targets Nrf2 for proteasomal degradation. Keap1 carries a set of reactive cysteine residues. When those cysteines are modified by an electrophilic or oxidative stimulus, Keap1 releases Nrf2, which translocates to the nucleus, dimerizes with small Maf proteins, and binds antioxidant response elements (AREs) in the promoter regions of more than 200 cytoprotective genes.

The Nrf2 target gene set includes:

Epigallocatechin gallate activates Nrf2 indirectly: at modest concentrations it produces a low-grade oxidative or electrophilic signal in the cell that modifies Keap1's reactive cysteines, releasing Nrf2 to translocate to the nucleus and induce the cytoprotective response. The cell, in effect, perceives epigallocatechin gallate as a mild stressor and ramps up its endogenous antioxidant defenses in response. This is the hormesis principle that underlies much of the polyphenol-and-health story.

The implication is that the meaningful antioxidant benefit of green tea is not the direct quenching done by the epigallocatechin gallate molecules circulating in plasma. It is the elevated steady-state glutathione, superoxide dismutase, and catalase activity in tissues that results from chronic mild Nrf2 stimulation. This is why habitual tea consumption produces measurable reductions in oxidative DNA damage markers (urinary 8-hydroxy-2'-deoxyguanosine), F2-isoprostanes, and lipid peroxidation products — while acute single-dose tea consumption typically does not.

Back to Table of Contents

Iron Chelation and the Mealtime Question

The vicinal triol on the epigallocatechin gallate B-ring is an excellent chelator of ferric (Fe3+) iron. When tea is consumed with a meal, epigallocatechin gallate and the other catechins bind dietary non-heme iron in the lumen of the small intestine, forming insoluble polyphenol-iron complexes that are not absorbed. The classic Hallberg and Rossander study (1982) found that tea served with a meal reduced non-heme iron absorption by 62% — a larger reduction than coffee produced (35%), while milk had no significant effect.

This is clinically meaningful in two opposite directions:

  1. Iron-deficient population (premenopausal women, vegetarians, gastric bypass patients, chronic blood loss) — tea drunk with meals contributes to iron-deficiency risk; the reduction above was measured with tea served at the meal itself, and a gap of 1-2 hours between tea and iron-rich meals is the separation commonly described. This interaction matters most for habitual green tea drinkers who are female of reproductive age or have any other risk factor for iron deficiency.
  2. Iron-overload population (hereditary hemochromatosis, thalassemia, repeat-transfusion recipients) — tea consumption with meals can be a useful adjunct to phlebotomy or chelation therapy by reducing dietary iron absorption. Small clinical series have explored green tea extract as adjunctive therapy in thalassemia major.

The chelation also has an indirect antioxidant benefit: chelating intestinal iron prevents iron-catalyzed lipid peroxidation in the gut lumen, which has been hypothesized as one mechanism by which polyphenol-rich diets reduce colorectal cancer risk. The same chelation chemistry contributes to systemic antioxidant effect by reducing free-iron-driven Fenton chemistry in tissues, although the magnitude of the systemic effect is modest because absorbed epigallocatechin gallate plasma concentrations are low.

For more on iron physiology, see our Iron page. For tea drinkers who are iron-deficient, the relevant point is that the effect was measured with tea drunk alongside the meal. Coffee has the same interaction (though smaller) due to its chlorogenic acid content.

Back to Table of Contents

Epigallocatechin Gallate Bioavailability — The Real-World Plasma Curve

Epigallocatechin gallate bioavailability from brewed green tea is poor by pharmaceutical standards. Peak plasma epigallocatechin gallate concentrations after a typical cup of tea (containing 50-100 mg epigallocatechin gallate) are in the 0.1-0.5 micromolar range, with peak time around 90-150 minutes and an elimination half-life of approximately 3-5 hours. After a higher dose (200-400 mg epigallocatechin gallate from concentrated extract), peak concentrations reach 1-3 micromolar.

A 2002 pharmacokinetic study by Lee and colleagues gives measured figures. Eight people drank green tea made from 20 mg of tea solids per kg of body weight; epigallocatechin gallate peaked in plasma at 77.9 ng/ml, catechin peaks came 1.3-1.6 hours after drinking, and the elimination half-life of epigallocatechin gallate was about 3.4 hours. In plasma, epigallocatechin gallate was mostly in its free form, while EGC and EC were mostly conjugated, and the results varied considerably between people and between repeated tests.

Several factors limit oral bioavailability:

One practical implication: taking epigallocatechin gallate on an empty stomach roughly doubles peak plasma concentrations compared to taking it with food. This is one reason high-dose concentrated green tea extract supplements taken on an empty stomach have been associated with idiosyncratic hepatotoxicity at much lower nominal doses than equivalent epigallocatechin gallate intake from food.

A second practical implication: epigallocatechin gallate plasma concentrations from realistic tea consumption never reach the high-micromolar concentrations used in most in vitro studies of epigallocatechin gallate anticancer or anti-inflammatory activity. Translation from cell culture to whole organism for epigallocatechin gallate is more strained than for most nutraceuticals. The meaningful in vivo effects of habitual tea consumption are mediated more by Nrf2 induction, gut-microbiome metabolite formation, and chronic low-grade signaling than by acute high-concentration direct effects.

Back to Table of Contents

Dose-Response and the Effective Cup Count

Epidemiologic and clinical-trial data converge on a roughly 3-5 cup per day intake as the range where measurable benefits on cardiovascular, metabolic, and cancer-related endpoints emerge. The Ohsaki cohort (Kuriyama 2006, 40,530 Japanese adults) found that, compared with drinking less than one cup per day, drinking five or more cups per day was linked to 12% lower all-cause mortality in men and 23% lower in women, and to 31% lower cardiovascular mortality in women, with a significant trend across the intake categories. Cancer mortality was not lower in any green tea category.

Typical epigallocatechin gallate content per cup varies considerably by leaf grade, brewing technique, and steep time. A standard 8-ounce cup of typical Japanese sencha brewed at 80°C for 2 minutes delivers roughly 50-100 mg epigallocatechin gallate. Matcha delivers substantially more because the whole leaf is consumed — a typical 2-gram serving of ceremonial-grade matcha delivers approximately 130-180 mg epigallocatechin gallate. Loose-leaf gyokuro is intermediate. Tea-bag green tea is typically lower per serving.

How the intake levels compare:

Back to Table of Contents

The Dose-Toxicity Inversion (Pro-Oxidant Behavior)

At physiologic concentrations (the low micromolar range achieved by brewed tea), epigallocatechin gallate behaves as an antioxidant through the mechanisms described above. At supraphysiologic concentrations (high micromolar to millimolar, achievable only through concentrated extract supplementation), epigallocatechin gallate inverts to a pro-oxidant.

The chemistry behind the inversion involves epigallocatechin gallate autoxidation. In aqueous solution at neutral pH, epigallocatechin gallate slowly oxidizes by losing hydrogens to molecular oxygen, generating hydrogen peroxide and epigallocatechin gallate quinone intermediates as byproducts. At low epigallocatechin gallate concentrations the hydrogen peroxide is rapidly neutralized by cellular catalase and glutathione peroxidase. At high concentrations, hydrogen peroxide generation outpaces the cell's ability to neutralize it, and the result is oxidative stress driven by the supposed antioxidant.

Epigallocatechin gallate quinones are also electrophilic and can covalently modify protein thiols, including critical cellular machinery like glutathione, glutathione S-transferase, and various mitochondrial proteins. The net effect of high-dose epigallocatechin gallate exposure in cell culture and in animal models is mitochondrial dysfunction, glutathione depletion, hepatocyte apoptosis, and acute hepatocellular injury — the opposite of the antioxidant effect at low dose.

This inversion is the underlying mechanism behind the green tea extract hepatotoxicity case series. Concentrated epigallocatechin gallate capsules taken on an empty stomach push plasma epigallocatechin gallate concentrations into the pro-oxidant range, particularly when the individual carries genetic variants that reduce hepatic epigallocatechin gallate conjugation or clearance. The brewed beverage essentially never reaches these concentrations.

Back to Table of Contents

Hepatotoxicity and the European Food Safety Authority 800 mg Finding

The published literature on green tea extract hepatotoxicity now includes more than 100 case reports of acute hepatocellular injury attributed to concentrated epigallocatechin gallate supplements, with onset usually weeks to months after starting the product: in the US Drug-Induced Liver Injury Network, symptoms began 15-448 days after starting (median 72 days), and a 2015 review found a mean latency of about 179 days for products containing only green tea, against about 45 days for multi-ingredient products. Liver injury patterns are typically hepatocellular (elevated alanine aminotransferase (ALT) and aspartate aminotransferase (AST)) rather than cholestatic, with R-ratios >5. Histology when biopsy is performed shows hepatocyte necrosis with variable inflammatory infiltrate.

Two literature reviews by Mazzanti and colleagues collected the published cases. The 2009 review found 34 published cases of hepatitis (1999 to October 2008) plus two new cases from the Italian surveillance system, with a positive rechallenge (the injury returning when the product was taken again) in seven cases, and noted that other medicines taken at the same time could be involved in a few cases. The 2015 update found 19 cases (late 2008 to March 2015), 12 of them involving multi-ingredient products. Factors discussed as raising risk include:

The European Food Safety Authority published a scientific opinion on green tea catechins in 2018. It did not set an upper limit or require labelling; its finding was that interventional trials showed that 800 mg or more of epigallocatechin gallate a day, taken as a food supplement, produced a statistically significant rise in liver enzymes (serum transaminases) compared with controls. It estimated that green tea infusions supply on average 90-300 mg of epigallocatechin gallate a day to European adults (up to 866 mg in high-level consumers), while food supplements supply 5-1,000 mg a day. It judged catechins from traditionally prepared green tea infusions to be in general safe at the intakes reported in European countries, while noting that rare cases of liver injury, most probably idiosyncratic, have also been reported after drinking green tea infusions.

A large clinical series comes from the US Drug-Induced Liver Injury Network (Hoofnagle 2021). Of 1,414 liver-injury cases that underwent formal causality assessment, 40 (3%) were attributed to green tea. The injury was hepatocellular in 95%, most patients were jaundiced (83%), 14 cases (35%) were severe, and 3 people (8%) needed a liver transplant; in three people the injury came back when they took green tea again. Symptoms began 15-448 days (median 72) after starting the product. The gene variant HLA-B*35:01 was found in 72% of the green tea cases, against 15% of cases caused by other supplements, 12% of drug cases and 11% of population controls, which the authors read as a sign that the injury is idiosyncratic and immune-mediated.

The overall pattern: the benefits seen in population studies came from drinking brewed tea, while the liver-injury reports come mostly from concentrated extract supplements. Where concentrated epigallocatechin gallate has been used in research, such as some cancer-adjunct protocols, it was given in monitored settings.

Back to Table of Contents

Concentrated Supplement Versus Brewed Beverage

The difference between brewed green tea and concentrated epigallocatechin gallate capsules is not just a matter of dose, but of pharmacokinetics, matrix protection, and risk-benefit profile. A summary comparison:

In the research summarised here, green tea was studied as a beverage, not a supplement: the benefits documented in epidemiologic cohorts came from drinking tea, not from taking pills, while the liver-injury reports come mostly from concentrated extracts. The dose-toxicity inversion at high epigallocatechin gallate concentrations is a real concern that does not apply to the brewed beverage at any reasonable consumption level.

Back to Table of Contents

Drug Interactions and Cautions

Back to Table of Contents

Key Research Papers

  1. Higdon JV, Frei B (2003). Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Critical Reviews in Food Science and Nutrition. — PubMed PMID: 12587987
  2. Yang CS et al. (2009). Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nature Reviews Cancer. — PubMed PMID: 19472429
  3. Mazzanti G, Menniti-Ippolito F, Moro PA, et al. (2009). Hepatotoxicity from green tea: a review of the literature and two unpublished cases. European Journal of Clinical Pharmacology. — PubMed PMID: 19198822
  4. Mazzanti G, Di Sotto A, Vitalone A (2015). Hepatotoxicity of green tea: an update. Archives of Toxicology. — PubMed PMID: 25975988
  5. Hoofnagle JH, Bonkovsky HL, Phillips EJ, et al.; Drug-Induced Liver Injury Network (2021). HLA-B*35:01 and green tea-induced liver injury. Hepatology. — PubMed PMID: 32892374
  6. EFSA Panel on Food Additives and Nutrient Sources (2018). Scientific opinion on the safety of green tea catechins. EFSA Journal. — PubMed PMID: 32625874
  7. Na HK, Surh YJ (2008). Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG. Food and Chemical Toxicology. — PubMed PMID: 18082923
  8. Lambert JD, Elias RJ (2010). The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention. Archives of Biochemistry and Biophysics. — PubMed PMID: 20558130
  9. Hallberg L, Rossander L (1982). Effect of different drinks on the absorption of non-heme iron from composite meals. Human Nutrition: Applied Nutrition. — PubMed PMID: 6896705
  10. Lee MJ et al. (2002). Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiology, Biomarkers and Prevention. — PubMed PMID: 12376503
  11. Sang S, Lambert JD, Ho CT, Yang CS (2011). The chemistry and biotransformation of tea constituents. Pharmacological Research. — PubMed PMID: 21371557
  12. Shen CL et al. (2009). Green tea and bone metabolism. Nutrition Research. — PubMed PMID: 19700031
  13. Hsu CH et al. (2008). Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial. Clinical Nutrition. — PubMed PMID: 18468736
  14. Kuriyama S, Shimazu T, Ohmori K, et al. (2006). Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA. — PubMed PMID: 16968850
  15. Misaka S, Yatabe J, Müller F, et al. (2014). Green tea ingestion greatly reduces plasma concentrations of nadolol in healthy subjects. Clinical Pharmacology and Therapeutics. — PubMed PMID: 24419562
  16. Misaka S, Ono Y, Uchida A, et al. (2021). Impact of green tea catechin ingestion on the pharmacokinetics of lisinopril in healthy volunteers. Clinical and Translational Science. — PubMed PMID: 33048477
  17. Misaka S, Ono Y, Taudte RV, et al. (2022). Exposure of fexofenadine, but not pseudoephedrine, is markedly decreased by green tea extract in healthy volunteers. Clinical Pharmacology and Therapeutics. — PubMed PMID: 35678032
  18. Golden EB, Lam PY, Kardosh A, et al. (2009). Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood. — PubMed PMID: 19190249

PubMed Topic Searches

  1. PubMed: EGCG and Nrf2 antioxidant response
  2. PubMed: EGCG pharmacokinetics
  3. PubMed: Green tea extract hepatotoxicity
  4. PubMed: Catechin iron chelation
  5. PubMed: EGCG pro-oxidant behavior

Back to Table of Contents

Connections

Back to Table of Contents